The Alzheimer’s Drug Discovery Foundation (ADDF) and the Harrington Discovery Institute are calling for proposals for their…
Ana de Barros, PhD
Ana holds a PhD in immunology from the University of Lisbon and worked as a postdoctoral researcher at Instituto de Medicina Molecular (iMM) in Lisbon, Portugal. Ana was awarded two FCT fellowships and has won the Portuguese Immunology Society Best Paper and Best Poster award in 2009 and 2010, as well as the CESPU International Research Award in 2010. After leaving the lab to pursue a career in science communication, she served as the director of science communication at iMM Lisbon.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Ana de Barros, PhD
Honor is collaborating with the Alzheimer’s Association to educate its Care Pros on how to better care for people living…
Neither high cholesterol intake nor daily egg consumption increases the risk of dementia or Alzheimer’s disease (AD), according to a…
Researchers at Rush and Harvard universities are preparing a pioneering clinical trial to evaluate the impact of diet in preventing…
Pharnext  is reporting positive Phase 2 results from its investigative pleodrug PXT-864, a new oral combination of existing therapies, for the treatment of Alzheimer’s…
Researchers have found that 75% of older adults would take a free and definitive test predictive of Alzheimer’s disease…
Proclara Biosciences has announced two additional patents in its effort to develop therapies for neurodegenerative diseases such as…
Two years of in-home occupational therapy, added to collaborative care, did not slow the rate of functional decline — the…
A new research study has found that the use of benzodiazepines and related drugs increases the risk of hip fracture…
A study led by Finnish researchers found that long-term use of opioids, painkillers that can be addictive, is common among people…